63 phenotypes from 3 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Lamp2tm1.2Ces/Y involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL	abnormal autophagy	J:328713
	abnormal myocardial fiber morphology	J:328713
	abnormal myocardial fiber physiology	J:328713
	abnormal sinoatrial node conduction	J:328713
	atrioventricular block	J:328713
	normal behavior/neurological phenotype	J:328713
	cardiac fibrosis	J:328713
	cardiac hypertrophy	J:328713
	cardiomyopathy	J:328713
	decreased birth body size	J:328713
	decreased cardiac muscle contractility	J:328713
	dilated heart left ventricle	J:328713
	heart left ventricle hypertrophy	J:328713
	increased cardiac muscle glycogen level	J:328713
	increased circulating troponin T level	J:328713
	increased heart weight	J:328713
	irregular heartbeat	J:328713
	neonatal lethality, incomplete penetrance	J:328713
	prolonged PR interval	J:328713
Lamp2tm1Amcu/Y Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J	abnormal autophagy	J:215605
	abnormal enzyme/coenzyme activity	J:215605
	abnormal glucose homeostasis	J:215605
	abnormal lipid homeostasis	J:215605
	abnormal liver physiology	J:215605
	normal cellular phenotype	J:215605
	decreased body weight	J:215605
	decreased brown fat cell lipid droplet size	J:215605
	decreased fasting circulating glucose level	J:215605
	decreased gonadal fat pad weight	J:215605
	decreased hepatic glucose production	J:215605
	decreased liver function	J:215605
	decreased liver glycogen level	J:215605
	decreased locomotor activity	J:215605
	decreased percent body fat/body weight	J:215605
	decreased white fat cell lipid droplet size	J:215605
	enhanced behavioral response to xenobiotic	J:215605
	enlarged liver	J:215605
	hepatic steatosis	J:215605
	improved glucose tolerance	J:215605
	increased carbon dioxide production	J:215605
	increased cellular glucose import	J:215605
	increased circulating alanine transaminase level	J:215605
	increased energy expenditure	J:215605
	increased hepatocyte apoptosis	J:215605
	increased liver triglyceride level	J:215605
	increased liver weight	J:215605
	increased oxygen consumption	J:215605
	increased respiratory quotient	J:215605
	increased susceptibility to weight gain	J:215605
	pale liver	J:215605
	weight loss	J:215605
Lamp2tm1Psa/Lamp2tm1Psa either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv)	abnormal cell physiology	J:64151
	abnormal circulating amino acid level	J:64151
	abnormal thymus morphology	J:64151
	decreased body weight	J:64151
	decreased cardiac muscle contractility	J:64151
	decreased litter size	J:64151
	increased heart weight	J:64151
	intermingled spleen red and white pulp	J:64151
	premature death	J:64151
Lamp2tm1Psa/Lamp2tm1Psa involves: 129P2/OlaHsd	abnormal cardiovascular system physiology	J:253728
	abnormal cellular respiration	J:253728
	abnormal mitochondrial morphology	J:253728
	abnormal mitophagy	J:253728
	abnormal myocardial fiber physiology	J:253728
	impaired autophagy	J:253728
	increased heart left ventricle wall thickness	J:253728
	increased myocardial fiber size	J:253728